Articles with "response liraglutide" as a keyword



Photo by iamjadedestiny from unsplash

Response to “Liraglutide effect on epicardial fat: Missing the forest for the trees”

Sign Up to like & get
recommendations!
Published in 2017 at "Obesity"

DOI: 10.1002/oby.21843

Abstract: TO THE EDITOR: I thank you for the opportunity to respond to Munoz and colleagues’ comments and expand the discussion on our recently published paper (1). We pioneered the research on epicardial adipose tissue (2).… read more here.

Keywords: epicardial fat; liraglutide effect; fat missing; effect epicardial ... See more keywords
Photo from wikipedia

Potential contributors to variation in weight‐loss response to liraglutide

Sign Up to like & get
recommendations!
Published in 2023 at "Obesity Reviews"

DOI: 10.1111/obr.13568

Abstract: Obesity treatment requires a chronic state of negative energy balance. Obesity medications can help with this, increasing long‐term dietary compliance by promoting satiety or reducing hunger. However, efficacy and safety of obesity medications vary for… read more here.

Keywords: loss; loss response; obesity medications; weight loss ... See more keywords
Photo from wikipedia

Prediction scale of response to liraglutide therapy as the method for increase of treatment efficacy in type 2 diabetes

Sign Up to like & get
recommendations!
Published in 2022 at "Future Science OA"

DOI: 10.2144/fsoa-2021-0070

Abstract: Background: The effects of liraglutide on body weight and hemoglobin A1C (HbA1c) level vary greatly. The cost of this drug negatively affects treatment adherence. Aim: To reveal the baseline patient characteristics, associated with a better… read more here.

Keywords: prediction scale; efficacy; treatment; response ... See more keywords
Photo from wikipedia

Clinical and Genetic Predictors of Glycemic Control and Weight Loss Response to Liraglutide in Patients with Type 2 Diabetes

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of Personalized Medicine"

DOI: 10.3390/jpm12030424

Abstract: Background: Evidence suggests a heterogeneous response to therapy with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in patients with type 2 diabetes mellitus (T2DM). The aim of this study is to identify the genetic and clinical… read more here.

Keywords: response liraglutide; response; weight loss; glycemic control ... See more keywords